KRas-IN-1

CAS No. 84783-01-7

KRas-IN-1( MDK-3017 | MDK3017 | MDK 3017 | K-Ras-IN-2 | K-Ras Inhibitor-2 )

Catalog No. M16153 CAS No. 84783-01-7

A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 140 In Stock
5MG 237 In Stock
10MG 357 In Stock
25MG 597 In Stock
50MG 851 In Stock
100MG 1152 In Stock
500MG 2313 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KRas-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.
  • Description
    A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM; binds to K-Ras in a hydrophobic pocket that is occupied by Tyr-71 in the apo-Ras crystal structure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDK-3017 | MDK3017 | MDK 3017 | K-Ras-IN-2 | K-Ras Inhibitor-2
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    84783-01-7
  • Formula Weight
    207.292
  • Molecular Formula
    C11H13NOS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 28 mg/mL
  • SMILES
    S=C(C1=CC=CC=C1O)N2CCCC2
  • Chemical Name
    Methanethione, (2-hydroxyphenyl)-1-pyrrolidinyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sun Q, et al. Angew Chem Int Ed Engl. 2012 Jun 18;51(25):6140-3.
molnova catalog
related products
  • RAS activator compou...

    RAS activator compound 1 is a small molecule RAS activator compound that increases the rate of SOS-catalyzed nucleotide exchange in vitro with EC50 of 14 uM.

  • K-Ras G12C-IN-3

    A novel and irreversible inhibitor of mutant K-ras G12C.

  • KRAS G12C inhibitor ...

    A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.